Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Medical Specialties
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| ISRG | Intuitive Surgical, Inc. | -1.20% | 518.06 | 2.4% | $385.68m | |
| MDT | Medtronic PLC | -0.72% | 87.72 | 0.6% | $361.23m | |
| ABMD | ABIOMED, Inc. | 0.15% | 419.38 | 3.3% | $305.71m | |
| ALGN | Align Technology, Inc. | -0.32% | 362.28 | 6.3% | $297.32m | |
| ABT | Abbott Laboratories | -2.01% | 61.79 | 0.8% | $283.97m | |
| BDX | Becton, Dickinson and Company | -0.80% | 245.13 | 1.1% | $259.38m | |
| TMO | Thermo Fisher Scientific Inc. | -1.20% | 208.67 | 1.0% | $248.97m | |
| BSX | Boston Scientific Corporation | -0.66% | 33.13 | 1.1% | $192.35m | |
| SYK | Stryker Corporation | -0.53% | 173.38 | 1.3% | $182.39m | |
| EW | Edwards Lifesciences Corporation | -0.99% | 146.67 | 1.2% | $167.19m | |
| BAX | Baxter International Inc. | -1.04% | 74.00 | 1.7% | $163.49m | |
| COO | Cooper Companies, Inc. | -1.82% | 242.63 | 2.2% | $106.93m | |
| WAT | Waters Corporation | -2.32% | 193.50 | 3.4% | $100.45m | |
| ZBH | Zimmer Biomet Holdings, Inc. | -1.97% | 112.63 | 1.7% | $95.52m | |
| XRAY | DENTSPLY International Inc. | -1.39% | 44.72 | 3.0% | $94.41m |
Company Profile
Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. It operates through the following geographical segments: United States, Europe, Japan, and Rest of the World. Its products are categorized into three areas: Surgical Heart Valve Therapy, Transcatheter Heart Valves, and Critical Care. The Surgical Heart Valve Therapy portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The portfolio also includes a diverse line of cardiac surgery systems used during minimally invasive surgical procedures, and cannulae, embolic protection devices and other products used during cardiopulmonary bypass. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. Its portfolio includes technologies designed for nonsurgical replacement of heart valves. The Critical Care portfolio products hemodynamic monitoring systems used to measure a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA..